Jea Young Min is a Research Scientist in the Therapeutics and Infectious Disease Epidemiology group at the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She currently works on the FDA-sponsored Sentinel Initiative for drug safety surveillance. Her research interests include studying the safety and effectiveness of chronic disease medications and evaluating the safety of prescription drug use in pregnancy.
Dr. Min has a background in clinical pharmacy and received her Doctor of Pharmacy degree from the University of Iowa. She also holds a Master of Public Health from Emory University and a PhD in Epidemiology from Vanderbilt University. During her doctoral training, Dr. Min’s research focused primarily on studying the comparative effectiveness of second-line antidiabetic drugs using large administrative claims databases and electronic health record data. Prior to joining the Department of Population Medicine, she worked as a Research Associate in the Department of Population Health Sciences at Weill Cornell Medical College in New York.